DC

Dan Chaplin

Investor at Bondaval

London, England

Overview 

Dan Chaplin is a Partner at Dawn Capital in London, with a strong track record of successful investments in companies like Omi and Cover Genius. He has held key roles as an investor and board director in various successful ventures, demonstrating expertise in Enterprise and FinTech sectors. Dan's career highlights include leading investments in Omi during its Series A stage and Cover Genius during its Series E stage, showcasing his ability to identify and support high-growth companies at different stages of development.

Work Experience 

  • Partner

    2018 - Current

    Leading fintech investments at Dawn, Europe's largest specialist B2B software VC, supporting founders building the next generation of global software leaders. Investments include Access Fintech, Billie, Bondaval, Brite, Copper, Cover Genius, Eigen Technologies, Elwood, Omi, OpenGamma, Tink [VISA]

  • Investor and Board Director

    2024

  • Investor and Board Director

    2023

  • Investor and Board Director

    2022

  • Investor and Board Director

    2022

  • Investor and Board Observer

    2022

  • Investor and Board Observer

    2021

  • Investor and Board Observer

    2021

  • Angel Investor

    2021

Lindus Health is a next-gen CRO running clinical trials for the health and biotech sectors.

Raised $24,545,079.00 from Seedcamp, Peter Thiel, Page One Ventures, Salica, Calm/Storm Ventures, Amino Collective, Firstminute Capital and Creandum.

  • Investor and Board Observer

    2020

AccessFintech offers risk management services for banks and buyside firms and tracks the trade lifecycle.

Raised $97,500,000.00 from Goldman Sachs, BNP Paribas Securities Services, Citi, Dawn Capital, Bank of America, JP Morgan, BNY, GS Growth and WestCap.

Articles About Dan

Relevant Websites